{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:56Z","timestamp":1792783136471,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004926","name":"Texas Higher Education Coordinating Board","doi-asserted-by":"publisher","award":["NHARP Program"],"award-info":[{"award-number":["NHARP Program"]}],"id":[{"id":"10.13039\/100004926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004926","name":"Texas Higher Education Coordinating Board","doi-asserted-by":"publisher","award":["Grant #01994"],"award-info":[{"award-number":["Grant #01994"]}],"id":[{"id":"10.13039\/100004926","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chapman University","id":[{"id":"https:\/\/ror.org\/0452jzg20","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Cytochrome P450 (P450) metabolites of arachidonic acid (AA) are potential therapeutic targets in ischemia\u2013reperfusion (IR) injury, yet their disposition and actions in hepatic IR are unknown. Cellular AA and its P450 metabolites are primarily bound to lipid membranes, resulting in negligible free concentrations. This study investigates how hepatic IR injury impacts the disposition of free AA and its major P450 metabolites in rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Rats underwent 60 min of partial (70%) ischemia or sham surgery, followed by 5 min, 3 h, or 24 h of reperfusion. The effects of IR injury on free concentrations of AA and its major P450-generated metabolites in the liver were studied using LC\u2013MS\/MS. The activities of phospholipase A\n                      <jats:sub>2<\/jats:sub>\n                      (PLA\n                      <jats:sub>2<\/jats:sub>\n                      ) enzymes, which release AA and its preformed metabolites from lipid membranes, were also measured in the liver and plasma. Additionally,\n                      <jats:italic>in vitro<\/jats:italic>\n                      rates of metabolite formation and the levels of major AA-metabolizing enzymes were assessed in microsomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Hepatic IR injury significantly increased free liver concentrations of AA (sevenfold) and its metabolites (1.8\u20139.1-fold) only in the 5-min group. Similarly, PLA\n                      <jats:sub>2<\/jats:sub>\n                      enzyme activity in the liver and plasma was higher only in this group. Conversely, liver IR injury caused a significant reduction or no change in the\n                      <jats:italic>in vitro<\/jats:italic>\n                      rate of AA metabolism to P450-mediated metabolites in the 5-min group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Liver IR injury rapidly increases liver concentrations of free P450-mediated metabolites of AA, likely due to IR-induced release of preformed metabolites and AA from lipid membranes, rather than an increase in P450 enzymatic activity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11095-026-04108-1","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T22:31:49Z","timestamp":1779489109000},"page":"2667-2682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Normothermic Hepatic Ischemia\u2013Reperfusion Injury on the Hepatic Disposition of Arachidonic Acid and Its Cytochrome P450-Generated Metabolites in Rats"],"prefix":"10.1007","volume":"43","author":[{"given":"Vindhya","family":"Edpuganti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1770-0391","authenticated-orcid":false,"given":"Reza","family":"Mehvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"2","key":"4108_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrgastro.2012.225","volume":"10","author":"Y Zhai","year":"2013","unstructured":"Zhai Y, Petrowsky H, Hong JC, Busuttil RW, Kupiec-Weglinski JW. Ischaemia-reperfusion injury in liver transplantation-from bench to bedside. Nat Rev Gastroenterol Hepatol. 2013;10(2):79\u201389.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"4108_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3350\/cmh.2024.0222","volume":"30","author":"J Liu","year":"2024","unstructured":"Liu J, Luo R, Zhang Y, Li X. Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury. Clin Mol Hepatol. 2024;30(4):585\u2013619.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"4108_CR3","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/S0016-5085(03)01209-5","volume":"125","author":"H Jaeschke","year":"2003","unstructured":"Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia\/reperfusion injury. Gastroenterology. 2003;125(4):1246\u201357.","journal-title":"Gastroenterology"},{"issue":"3","key":"4108_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/08941930390205773","volume":"16","author":"H Jaeschke","year":"2003","unstructured":"Jaeschke H. Role of reactive oxygen species in hepatic ischemia-reperfusion injury and preconditioning. J Invest Surg. 2003;16(3):127\u201340.","journal-title":"J Invest Surg"},{"key":"4108_CR5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/liv.14091","volume":"39","author":"WA Dar","year":"2019","unstructured":"Dar WA, Sullivan E, Bynon JS, Eltzschig H, Ju C. Ischemia reperfusion injury in liver transplantation: cellular and molecular mechanisms. Liver Int. 2019;39:788\u2013801.","journal-title":"Liver Int"},{"key":"4108_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103258","volume":"75","author":"J George","year":"2024","unstructured":"George J, Lu Y, Tsuchishima M, Tsutsumi M. Cellular and molecular mechanisms of hepatic ischemia-reperfusion injury: the role of oxidative stress and therapeutic approaches. Redox Biol. 2024;75:103258.","journal-title":"Redox Biol"},{"issue":"1-2","key":"4108_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1098-8823(03)00077-7","volume":"72","author":"D Sacerdoti","year":"2003","unstructured":"Sacerdoti D, Gatta A, McGiff JC. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology. Prostaglandins Other Lipid Mediat. 2003;72(1\u20132):51\u201371.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"4108_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther. 2021;6(1):94.","journal-title":"Signal Transduct Target Ther"},{"key":"4108_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114732","volume":"192","author":"ML Alvarez","year":"2021","unstructured":"Alvarez ML, Lorenzetti F. Role of eicosanoids in liver repair, regeneration and cancer. Biochem Pharmacol. 2021;192:114732.","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"4108_CR10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1073\/pnas.0308185100","volume":"101","author":"DJ Granville","year":"2004","unstructured":"Granville DJ, Tashakkor B, Takeuchi C, Gustafsson AB, Huang C, Sayen MR, et al. Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors. Proc Natl Acad Sci U S A. 2004;101(5):1321\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"4108_CR11","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1161\/01.RES.0000146277.62128.6f","volume":"95","author":"K Nithipatikom","year":"2004","unstructured":"Nithipatikom K, Gross ER, Endsley MP, Moore JM, Isbell MA, Falck JR, et al. Inhibition of cytochrome P450 omega-hydroxylase: a novel endogenous cardioprotective pathway. Circ Res. 2004;95(8):e65\u201371.","journal-title":"Circ Res"},{"issue":"6","key":"4108_CR12","first-page":"1245","volume":"37","author":"ER Gross","year":"2004","unstructured":"Gross ER, Nithipatikom K, Hsu AK, Peart JN, Falck JR, Campbell WB. Cytochrome P450 omega-hydroxylase inhibition reduces infarct size during reperfusion via the sarcolemmal KATP channel. J Mol Cell Cardiol. 2004;37(6):1245\u20139.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"4108_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.yjmcc.2008.09.711","volume":"46","author":"SN Batchu","year":"2009","unstructured":"Batchu SN, Law E, Brocks DR, Falck JR, Seubert JM. Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model. J Mol Cell Cardiol. 2009;46(1):67\u201374.","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"4108_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.103049","volume":"299","author":"ML Edin","year":"2023","unstructured":"Edin ML, Gruzdev A, Bradbury JA, Graves JP, Lih FB, DeGraff LM, et al. Disruption of Ephx2 in cardiomyocytes but not endothelial cells improves functional recovery after ischemia-reperfusion in isolated mouse hearts. J Biol Chem. 2023;299(4):103049.","journal-title":"J Biol Chem"},{"issue":"12","key":"4108_CR15","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/sj.jcbfm.9600309","volume":"26","author":"SM Poloyac","year":"2006","unstructured":"Poloyac SM, Zhang Y, Bies RR, Kochanek PM, Graham SH. Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia. J Cereb Blood Flow Metab. 2006;26(12):1551\u201361.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"4108_CR16","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1161\/STROKEAHA.124.049143","volume":"56","author":"H Geng","year":"2025","unstructured":"Geng H, Tang J, Li Z, Zhang Y, Ye C, Zhang Y, et al. 14,15-EET maintains mitochondrial homeostasis to inhibit neuronal pyroptosis after ischemic stroke. Stroke. 2025;56(7):1883\u201396.","journal-title":"Stroke"},{"issue":"5","key":"4108_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ki.2008.600","volume":"75","author":"KR Regner","year":"2009","unstructured":"Regner KR, Zuk A, Van Why SK, Shames BD, Ryan RP, Falck JR, et al. Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury. Kidney Int. 2009;75(5):511\u20137.","journal-title":"Kidney Int"},{"issue":"1","key":"4108_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ki.2010.377","volume":"79","author":"U Hoff","year":"2011","unstructured":"Hoff U, Lukitsch I, Chaykovska L, Ladwig M, Arnold C, Manthati VL, et al. Inhibition of 20-HETE synthesis and action protects the kidney from ischemia\/reperfusion injury. Kidney Int. 2011;79(1):57\u201365.","journal-title":"Kidney Int"},{"key":"4108_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117327","volume":"246","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Ding A, Yang D, Cui T, Yang H, Zhang H, et al. CYP2J2-produced epoxyeicosatrienoic acids attenuate ischemia\/reperfusion-induced acute kidney injury by activating the SIRT1-FoxO3a pathway. Life Sci. 2020;246:117327.","journal-title":"Life Sci"},{"issue":"2","key":"4108_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1549-8719.2009.00013.x","volume":"17","author":"MI Townsley","year":"2010","unstructured":"Townsley MI, Morisseau C, Hammock B, King JA. Impact of epoxyeicosatrienoic acids in lung ischemia-reperfusion injury. Microcirculation. 2010;17(2):137\u201346.","journal-title":"Microcirculation"},{"issue":"1","key":"4108_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.athoracsur.2011.08.074","volume":"93","author":"I Ali","year":"2012","unstructured":"Ali I, Gruenloh S, Gao Y, Clough A, Falck JR, Medhora M, et al. Protection by 20-5,14-HEDGE against surgically induced ischemia reperfusion lung injury in rats. Ann Thorac Surg. 2012;93(1):282\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"4108_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nm.4451","volume":"24","author":"XJ Zhang","year":"2018","unstructured":"Zhang XJ, Cheng X, Yan ZZ, Fang J, Wang X, Wang W, et al. An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury. Nat Med. 2018;24(1):73\u201383.","journal-title":"Nat Med"},{"issue":"1","key":"4108_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52379-2","volume":"15","author":"X Yang","year":"2024","unstructured":"Yang X, Chen H, Shen W, Chen Y, Lin Z, Zhuo J, et al. FGF21 modulates immunometabolic homeostasis via the ALOX15\/15-HETE axis in early liver graft injury. Nat Commun. 2024;15(1):8578.","journal-title":"Nat Commun"},{"key":"4108_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151891","volume":"766","author":"B Qian","year":"2025","unstructured":"Qian B, Jiang Z, Chen R, Yang T, He Z, Xie D, et al. Niacin attenuates hepatic ischemia-reperfusion injury via suppression of 15-HETE mediated inflammation. Biochem Biophys Res Commun. 2025;766:151891.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4108_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0022-2275(20)32049-6","volume":"41","author":"JH Capdevila","year":"2000","unstructured":"Capdevila JH, Falck JR, Harris RC. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J Lipid Res. 2000;41(2):163\u201381.","journal-title":"J Lipid Res"},{"issue":"1 Pt 2","key":"4108_CR26","first-page":"R217","volume":"270","author":"JD Imig","year":"1996","unstructured":"Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol. 1996;270(1 Pt 2):R217-27.","journal-title":"Am J Physiol"},{"issue":"6752","key":"4108_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/46816","volume":"401","author":"B Fisslthaler","year":"1999","unstructured":"Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999;401(6752):493\u20137.","journal-title":"Nature"},{"issue":"3","key":"4108_CR28","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1124\/jpet.104.080218","volume":"313","author":"AO Oyekan","year":"2005","unstructured":"Oyekan AO. Differential effects of 20-hydroxyeicosatetraenoic acid on intrarenal blood flow in the rat. J Pharmacol Exp Ther. 2005;313(3):1289\u201395.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"4108_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0026-895X(25)09593-8","volume":"38","author":"TD Lindstrom","year":"1990","unstructured":"Lindstrom TD, Hanssen BR, Bendele AM. Effects of hepatic ischemia-reperfusion injury on the hepatic mixed function oxidase system in rats. Mol Pharmacol. 1990;38(6):829\u201335.","journal-title":"Mol Pharmacol"},{"issue":"2","key":"4108_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/hep.1840150217","volume":"15","author":"SM Lee","year":"1992","unstructured":"Lee SM, Clemens MG. Effect of alpha-tocopherol on hepatic mixed function oxidases in hepatic ischemia\/reperfusion. Hepatology. 1992;15(2):276\u201381.","journal-title":"Hepatology"},{"key":"4108_CR31","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1002\/jps.22708","volume":"100","author":"IH Shaik","year":"2011","unstructured":"Shaik IH, Mehvar R. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats. J Pharm Sci. 2011;100:5281\u201392.","journal-title":"J Pharm Sci"},{"key":"4108_CR32","doi-asserted-by":"crossref","unstructured":"Cowled P, Fitridge R. Pathophysiology of Reperfusion Injury. In: Fitridge RTM, editor. Mechanisms of vascular disease: a reference book for vascular specialists [internet]. Adelaide: University of Adelaide Press; 2011. p. 331\u201350.","DOI":"10.1017\/UPO9781922064004.019"},{"key":"4108_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jchromb.2013.08.008","volume":"964","author":"V Edpuganti","year":"2014","unstructured":"Edpuganti V, Mehvar R. UHPLC-MS\/MS analysis of arachidonic acid and 10 of its major cytochrome P450 metabolites as free acids in rat livers: effects of hepatic ischemia. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;964:153\u201363.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"4108_CR34","volume-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","year":"2011","unstructured":"National Research Council. Guide for the Care and Use of Laboratory Animals. 8th Edition ed. Washington, D.C.: National Academies Press; 2011.","edition":"8th Edition ed"},{"issue":"4","key":"4108_CR35","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3109\/10715761003610729","volume":"44","author":"IH Shaik","year":"2010","unstructured":"Shaik IH, Mehvar R. Cytochrome P450 induction by phenobarbital exacerbates warm hepatic ischemia-reperfusion injury in rat livers. Free Radic Res. 2010;44(4):441\u201353.","journal-title":"Free Radic Res"},{"issue":"2","key":"4108_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jss.2014.06.024","volume":"191","author":"T Karatzas","year":"2014","unstructured":"Karatzas T, Neri AA, Baibaki ME, Dontas IA. Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms. J Surg Res. 2014;191(2):399\u2013412.","journal-title":"J Surg Res"},{"issue":"4","key":"4108_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.7555\/JBR.32.20180087","volume":"33","author":"S Rampes","year":"2019","unstructured":"Rampes S, Ma D. Hepatic ischemia-reperfusion injury in liver transplant setting: Mechanisms and protective strategies. J Biomed Res. 2019;33(4):221\u201334.","journal-title":"J Biomed Res"},{"key":"4108_CR38","first-page":"183","volume-title":"Biochemical Toxicology, a Practical Approach","author":"BG Lake","year":"1987","unstructured":"Lake BG. Preparation and characterisation of microsomal fractions for studies on xenobiotic metabolism. In: Snell K, Mullock B, editors. Biochemical Toxicology, a Practical Approach. Oxford, UK: IRL Press; 1987. p. 183\u2013215."},{"issue":"8","key":"4108_CR39","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1002\/jps.22531","volume":"100","author":"VC Pillai","year":"2011","unstructured":"Pillai VC, Mehvar R. Inhibition of NADPH-cytochrome P450 reductase by tannic acid in rat liver microsomes and primary hepatocytes: Methodological artifacts and application to ischemia-reperfusion injury. J Pharm Sci. 2011;100(8):3495\u2013505.","journal-title":"J Pharm Sci"},{"issue":"7","key":"4108_CR40","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","volume":"239","author":"T Omura","year":"1964","unstructured":"Omura T, Sato R. The carbon monoxide-binding pigment of the liver microsomes. Evidence for its hemoprotein nature. J Biol Chem. 1964;239(7):2370\u20138.","journal-title":"J Biol Chem"},{"issue":"9","key":"4108_CR41","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1016\/S0021-9258(18)53266-X","volume":"268","author":"DC Zeldin","year":"1993","unstructured":"Zeldin DC, Kobayashi J, Falck JR, Winder BS, Hammock BD, Snapper JR, et al. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J Biol Chem. 1993;268(9):6402\u20137.","journal-title":"J Biol Chem"},{"issue":"1","key":"4108_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0003-9861(85)90768-4","volume":"243","author":"J Capdevila","year":"1985","unstructured":"Capdevila J, Kim YR, Martin-Wixtrom C, Falck JR, Manna S, Estabrook RW. Influence of a fibric acid type of hypolipidemic agent on the oxidative metabolism of arachidonic acid by liver microsomal cytochrome P-450. Arch Biochem Biophys. 1985;243(1):8\u201319.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"4108_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1208\/s12248-012-9425-7","volume":"15","author":"AA El-Sherbeni","year":"2013","unstructured":"El-Sherbeni AA, Aboutabl ME, Zordoky BN, Anwar-Mohamed A, El-Kadi AO. Determination of the dominant arachidonic acid cytochrome P450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics. AAPS J. 2013;15(1):112\u201322.","journal-title":"AAPS J"},{"issue":"4","key":"4108_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bbalip.2006.03.014","volume":"1761","author":"MA Balboa","year":"2006","unstructured":"Balboa MA, Balsinde J. Oxidative stress and arachidonic acid mobilization. Biochim Biophys Acta. 2006;1761(4):385\u201391.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"4108_CR45","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1172\/JCI115202","volume":"87","author":"H Nakamura","year":"1991","unstructured":"Nakamura H, Nemenoff RA, Gronich JH, Bonventre JV. Subcellular characteristics of phospholipase A2 activity in the rat kidney. Enhanced cytosolic, mitochondrial, and microsomal phospholipase A2 enzymatic activity after renal ischemia and reperfusion. J Clin Invest. 1991;87(5):1810\u20138.","journal-title":"J Clin Invest"},{"issue":"2\u20133","key":"4108_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0304-3940(97)00646-0","volume":"233","author":"I Saluja","year":"1997","unstructured":"Saluja I, Song D, O\u2019Regan MH, Phillis JW. Role of phospholipase A2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex. Neurosci Lett. 1997;233(2\u20133):97\u2013100.","journal-title":"Neurosci Lett"},{"issue":"2","key":"4108_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s005400050032","volume":"13","author":"S Goto","year":"1999","unstructured":"Goto S, Nakamura H, Morooka H, Terao Y, Shibata O, Sumikawa K. Role of reactive oxygen in phospholipase A2 activation by ischemia\/reperfusion of the rat kidney. J Anesth. 1999;13(2):90\u20133.","journal-title":"J Anesth"},{"key":"4108_CR48","doi-asserted-by":"crossref","unstructured":"Yano T, Fujioka D, Saito Y, Kobayashi T, Nakamura T, Obata JE, et al. Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury. 2011;90(2):335\u201343.","DOI":"10.1093\/cvr\/cvq399"},{"issue":"1","key":"4108_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jss.2008.01.034","volume":"151","author":"DR Monbaliu","year":"2009","unstructured":"Monbaliu DR, Dubuisson CN, Zeegers MM, Crabbe MM, Fevery JM, Pirenne JM, et al. Increased serum phospholipase A2 activity after non-heart-beating donor liver transplantation and association with ischemia-reperfusion injury. J Surg Res. 2009;151(1):125\u201331.","journal-title":"J Surg Res"},{"issue":"3","key":"4108_CR50","first-page":"277","volume":"96","author":"Y Terao","year":"1997","unstructured":"Terao Y, Shibata O, Goto S, Morooka H, Nakamura H, Haseba S, et al. Phospholipase A2 is activated in the kidney, but not in the liver during ischemia-reperfusion. Res Commun Mol Pathol Pharmacol. 1997;96(3):277\u201389.","journal-title":"Res Commun Mol Pathol Pharmacol"},{"issue":"12","key":"4108_CR51","doi-asserted-by":"publisher","first-page":"7561","DOI":"10.1016\/S0021-9258(20)89484-8","volume":"266","author":"A Karara","year":"1991","unstructured":"Karara A, Dishman E, Falck JR, Capdevila JH. Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties. J Biol Chem. 1991;266(12):7561\u20139.","journal-title":"J Biol Chem"},{"issue":"6","key":"4108_CR52","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/ki.1997.234","volume":"51","author":"MA Carroll","year":"1997","unstructured":"Carroll MA, Balazy M, Huang DD, Rybalova S, Falck JR, McGiff JC. Cytochrome P450-derived renal HETEs: storage and release. Kidney Int. 1997;51(6):1696\u2013702.","journal-title":"Kidney Int"},{"issue":"4","key":"4108_CR53","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1074\/jbc.M306849200","volume":"279","author":"TL Kaduce","year":"2004","unstructured":"Kaduce TL, Fang X, Harmon SD, Oltman CL, Dellsperger KC, Teesch LM, et al. 20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells. J Biol Chem. 2004;279(4):2648\u201356.","journal-title":"J Biol Chem"},{"issue":"4 Pt 2","key":"4108_CR54","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1161\/01.HYP.25.4.854","volume":"25","author":"Y Zhu","year":"1995","unstructured":"Zhu Y, Schieber EB, McGiff JC, Balazy M. Identification of arachidonate P-450 metabolites in human platelet phospholipids. Hypertension. 1995;25(4 Pt 2):854\u20139.","journal-title":"Hypertension"},{"issue":"4","key":"4108_CR55","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/0006-291X(81)91597-7","volume":"101","author":"J Capdevila","year":"1981","unstructured":"Capdevila J, Parkhill L, Chacos N, Okita R, Masters BS, Estabrook RW. The oxidative metabolism of arachidonic acid by purified cytochromes P-450. Biochem Biophys Res Commun. 1981;101(4):1357\u201363.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4108_CR56","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/0003-9861(95)90023-3","volume":"320","author":"AB Rifkind","year":"1995","unstructured":"Rifkind AB, Lee C, Chang TK, Waxman DJ. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch Biochem Biophys. 1995;320(2):380\u20139.","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"4108_CR57","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/0003-9861(83)90628-8","volume":"223","author":"N Chacos","year":"1983","unstructured":"Chacos N, Capdevila J, Falck JR, Manna S, Martin-Wixtrom C, Gill SS, et al. The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase. Arch Biochem Biophys. 1983;223(2):639\u201348.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"4108_CR58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.bjp.0705758","volume":"142","author":"HA Eum","year":"2004","unstructured":"Eum HA, Lee SM. Effects of Trolox on the activity and gene expression of cytochrome P450 in hepatic ischemia\/reperfusion. Br J Pharmacol. 2004;142(1):35\u201342.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"4108_CR59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0021-5198(19)39732-X","volume":"58","author":"T Nagai","year":"1992","unstructured":"Nagai T, Egashira T, Kudo Y, Yamanaka Y, Shimada T. Attenuation of dysfunction in the ischemia-reperfused liver by glycyrrhizin. Jpn J Pharmacol. 1992;58(3):209\u201318.","journal-title":"Jpn J Pharmacol"},{"issue":"2","key":"4108_CR60","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0021-5198(19)53750-7","volume":"52","author":"T Nagai","year":"1990","unstructured":"Nagai T, Egashira T, Yamanaka Y. Effect of bifemelane hydrochloride on an injury of the liver caused by ischemia-reperfusion in rats. Jpn J Pharmacol. 1990;52(2):383\u20135.","journal-title":"Jpn J Pharmacol"},{"key":"4108_CR61","first-page":"27","volume":"13","author":"J Falero-Perez","year":"2018","unstructured":"Falero-Perez J, Song YS, Sorenson CM, Sheibani N. CYP1B1: a key regulator of redox homeostasis. Trends Cell Mol Biol. 2018;13:27\u201345.","journal-title":"Trends Cell Mol Biol"},{"issue":"1","key":"4108_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1124\/dmd.122.000915","volume":"51","author":"SH Gerges","year":"2023","unstructured":"Gerges SH, El-Kadi AOS. Sexual dimorphism in the expression of cytochrome P450 enzymes in rat heart, liver, kidney, lung, brain, and small intestine. Drug Metab Dispos. 2023;51(1):81\u201394.","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"4108_CR63","doi-asserted-by":"publisher","first-page":"478","DOI":"10.2133\/dmpk.20.478","volume":"20","author":"S Imaoka","year":"2005","unstructured":"Imaoka S, Hashizume T, Funae Y. Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs. Drug Metab Pharmacokinet. 2005;20(6):478\u201384.","journal-title":"Drug Metab Pharmacokinet"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04108-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04108-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04108-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:02:19Z","timestamp":1790010139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04108-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4108"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04108-1","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}